Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2005. Start Trial.
Date Value
October 23, 2026 1.375
October 22, 2026 1.375
October 21, 2026 1.386
October 20, 2026 1.351
October 19, 2026 1.322
October 16, 2026 1.323
October 15, 2026 1.323
October 14, 2026 1.317
October 13, 2026 1.293
October 12, 2026 1.348
October 09, 2026 1.330
October 08, 2026 1.346
October 07, 2026 1.318
October 06, 2026 1.305
October 05, 2026 1.322
October 02, 2026 1.313
October 01, 2026 1.353
September 30, 2026 1.360
September 29, 2026 1.350
September 28, 2026 1.363
September 25, 2026 1.347
September 24, 2026 1.376
September 23, 2026 1.363
September 22, 2026 1.395
September 21, 2026 1.438
Date Value
September 18, 2026 1.413
September 17, 2026 1.440
September 16, 2026 1.440
September 15, 2026 1.440
September 14, 2026 1.440
September 11, 2026 1.415
September 10, 2026 1.471
September 09, 2026 1.432
September 08, 2026 1.467
September 04, 2026 1.504
September 03, 2026 1.504
September 02, 2026 1.488
September 01, 2026 1.518
August 31, 2026 1.520
August 28, 2026 1.534
August 27, 2026 1.510
August 26, 2026 1.510
August 25, 2026 1.559
August 24, 2026 1.559
August 21, 2026 1.574
August 20, 2026 1.525
August 19, 2026 1.525
August 18, 2026 1.516
August 17, 2026 1.464
August 14, 2026 1.484

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
AstraZeneca PLC 11.27
GSK Plc 4.414
Novartis AG 6.777
Pfizer Inc. 1.993
Roche Holding AG --

Price to Book Value Related Metrics